TTOO (T2 Biosystems) E10: $-298.46 (As of Sep. 2024)


TTOO T2 Biosystems Inc TTOO
12 GF Score
Price $0.00
View Full Analysis

What is T2 Biosystems E10?

T2 Biosystems TTOO +25.00% 12 E10 is $-298.46 as of Sep. 2024. GuruFocus rates TTOO with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

T2 Biosystems's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.570. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-298.46 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), T2 Biosystems's current stock price is $0.0005. T2 Biosystems's E10 for the quarter that ended in Sep. 2024 was $-298.46. T2 Biosystems's Shiller PE Ratio of today is .


T2 Biosystems  (OTCPK:TTOO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


T2 Biosystems E10 Related Terms


T2 Biosystems E10 Historical Data

* Premium members only.

The historical data trend for T2 Biosystems's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T2 Biosystems E10 Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -314.42 -313.90

T2 Biosystems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -322.52 -313.90 -311.54 -306.71 -298.46

TTOO vs IDTA, NSTM, TMO: E10 Comparison

For the Diagnostics & Research subindustry, T2 Biosystems's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Shiller PE Ratio falls into.


TTOO
12GF Score
T2 Biosystems Inc TTOO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T2 Biosystems E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, T2 Biosystems's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.57/315.3010*315.3010
=-0.570

Current CPI (Sep. 2024) = 315.3010.

T2 Biosystems Quarterly Data

per share eps CPI Adj_EPS
201412 -45.000 234.812 -60.425
201503 -53.000 236.119 -70.773
201506 -54.000 238.638 -71.348
201509 -57.000 237.945 -75.531
201512 -56.000 236.525 -74.651
201603 -55.000 238.132 -72.823
201606 -58.000 241.018 -75.876
201609 -51.000 241.428 -66.605
201612 -48.000 241.432 -62.686
201703 -48.000 243.801 -62.077
201706 -50.000 244.955 -64.359
201709 -45.000 246.819 -57.486
201712 -51.000 246.524 -65.228
201803 -36.000 249.554 -45.484
201806 -32.000 251.989 -40.040
201809 -25.000 252.439 -31.225
201812 -35.000 251.233 -43.925
201903 -34.000 254.202 -42.172
201906 -35.000 256.143 -43.083
201909 -31.000 256.759 -38.068
201912 -29.000 256.974 -35.582
202003 -22.000 258.115 -26.874
202006 -9.000 257.797 -11.008
202009 -8.000 260.280 -9.691
202012 -6.692 260.474 -8.101
202103 -7.000 264.877 -8.333
202106 -8.000 271.696 -9.284
202109 -8.420 274.310 -9.678
202112 -7.000 278.802 -7.916
202203 -486.000 287.504 -532.988
202206 -510.000 296.311 -542.685
202209 -294.650 296.808 -313.009
202212 -141.000 296.797 -149.791
202303 -131.770 301.836 -137.648
202306 -7.840 305.109 -8.102
202309 -3.450 307.789 -3.534
202312 -2.548 306.746 -2.619
202403 -2.660 312.332 -2.685
202406 -0.640 314.175 -0.642
202409 -0.570 315.301 -0.570

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-298.46 mean?
T2 Biosystems (TTOO) has a E10 of $-298.46 as of Sep. 2024. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on T2 Biosystems and its competitors.
Is T2 Biosystems' E10 too high?
T2 Biosystems' current E10 is $-298.46. Overall, T2 Biosystems has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does T2 Biosystems' E10 compare to IDTA and NSTM?
T2 Biosystems' E10 of $-298.46 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on T2 Biosystems and its competitors. T2 Biosystems's current E10 is $-298.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T2 Biosystems stock overvalued right now?
T2 Biosystems (TTOO) has a current E10 of $-298.46. The current E10 is $-298.46. T2 Biosystems' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For T2 Biosystems (TTOO), the current E10 is $-298.46 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T2 Biosystems Business Description

Address 101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
12GF Score

Get the complete analysis for TTOO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price